SPIA
DNA icon

Steward Partners Investment Advisory’s Ginkgo Bioworks DNA Stock Holding History

Steward Partners Investment Advisory’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.03K Sell
608
-1
-0.2% -$8 ﹤0.01% 3903
2026
Q1 		$3.73K Sell
609
-45
-7% -$374 ﹤0.01% 3887
2025
Q4 		$5.43K Buy
654
+28
+4% +$302 ﹤0.01% 3669
2025
Q3 		$9.13K Sell
626
-682
-52% -$8.16K ﹤0.01% 3444
2025
Q2 		$14.7K Buy
1,308
+17
+1% +$132 ﹤0.01% 3035
2025
Q1 		$7.36K Hold
1,291
– – ﹤0.01% 3236
2024
Q4 		$12.7K Buy
1,291
+1
+0.1% +$9 ﹤0.01% 2999
2024
Q3 		$10.5K Buy
1,290
+1,110
+617% +$11.1K ﹤0.01% 2927
2024
Q2 		$2.41K Sell
180
-57
-24% -$1.7K ﹤0.01% 3245
2024
Q1 		$11K Sell
237
-161
-40% -$8.33K ﹤0.01% 2771
2023
Q4 		$26.9K Sell
398
-162
-29% -$9.92K ﹤0.01% 2260
2023
Q3 		$40.6K Buy
560
+75
+15% +$6K ﹤0.01% 1999
2023
Q2 		$36.1K Buy
485
+25
+5% +$1.48K ﹤0.01% 2019
2023
Q1 		$24.5K Buy
460
+110
+31% +$6.97K ﹤0.01% 2163
2022
Q4 		$23.7K Buy
350
+87
+33% +$8K ﹤0.01% 2157
2022
Q3 		$33K Buy
263
+139
+112% +$16.6K ﹤0.01% 1975
2022
Q2 		$12K Buy
124
+16
+15% +$1.95K ﹤0.01% 2440
2022
Q1 		$17K Buy
108
+35
+48% +$6.81K ﹤0.01% 2440
2021
Q4 		$24K Buy
73
+8
+12% +$3.8K ﹤0.01% 2241
2021
Q3 		$30K Buy
+65
New +$31.6K ﹤0.01% 2127

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Steward Partners Investment Advisory's DNA Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Ginkgo Bioworks (DNA) stake by 0.16% in Q2 2026, selling an estimated $8 and leaving 608 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #3903.

Steward Partners Investment Advisory first reported a position in DNA in Q3 2021 and has held it in 20 quarters since. The position peaked at $40.6K in Q3 2023. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Steward Partners Investment Advisory held 608 shares of Ginkgo Bioworks worth $6.03K as of Q2 2026.
  • Steward Partners Investment Advisory sold 1 Ginkgo Bioworks share in Q2 2026, an estimated $8.
  • Ginkgo Bioworks made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3903 holding.
  • Steward Partners Investment Advisory first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 20 quarters since.
  • Steward Partners Investment Advisory's Ginkgo Bioworks position peaked at $40.6K in Q3 2023.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.